-
QPRT, P2Y11 Signaling, and Breast Cancer Invasion
2026-09-11
The reference study identifies QPRT as a metabolic driver of breast cancer cell migration and invasion and links this phenotype to purinergic signaling and myosin light-chain phosphorylation. Its combination of expression analysis, genetic manipulation, tumor modeling, and pharmacological pathway interrogation provides a mechanistic framework for studying how NAD+ metabolism intersects with cytoskeletal control of metastasis.
-
Nigericin Sodium Salt: Practical Workflow Guide
2026-09-11
Nigericin sodium salt (SKU B7644) is a potassium ionophore for controlled studies of K+/H+ exchange, membrane ion gradients, cytoplasmic pH, and ion-dependent platelet responses. It is intended for research workflows only; it should not be used for diagnosis, patient treatment, or clinical inference from lead-ion transport observations.
-
NIH/3T3 Cells: Recovery, Culture, and QC
2026-09-10
NIH/3T3 Cells provide an adherent mouse fibroblast model for controlled culture, cell transfection studies, viral proliferation research, and oncogene research. This guide explains recovery, expansion, assay preparation, and QC while clarifying that the product dossier does not establish quantitative assay performance, viral permissiveness, or clinical applicability.
-
Vemurafenib: A Causal Probe of Melanoma Resistance
2026-09-10
Vemurafenib (PLX4032) is more than a BRAF V600E inhibitor: it is a precise pharmacological probe for connecting MAPK suppression with adaptive melanoma resistance. This guide translates multi-omics findings into genotype-aware assay design, handling decisions, and interpretable cancer biology workflows.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-09-09
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane-compromised cells. It is best suited to fixed samples, dead or apoptotic cells, fluorescence microscopy, and flow cytometry, rather than routine imaging of intact live cells.
-
Nanocarrier-Mediated dsRNA Translocation Across Cuticle
2026-09-09
This study provides a mechanistic explanation for how star cationic polymer nanocarriers help double-stranded RNA cross the insect cuticle. Its evidence links nanocomplex formation, wax-layer dissolution, improved wetting, altered chitin architecture, and reduced interfacial resistance, establishing a framework for noninvasive transdermal RNAi delivery.
-
SINAT–VAB1 Control of Autophagic Degradation
2026-09-08
A 2026 Arabidopsis study identifies VAB1, a V-ATPase subunit, as a SINAT-regulated determinant of autophagic vesicle degradation. By connecting SINAT-dependent ubiquitination of VAB1 with vacuolar acidification, the work explains how defective proteolysis can compromise nutrient-starvation tolerance and accelerate leaf senescence.
-
Glucocorticoids, Kv2.1, and CaV1.2 Signaling
2026-09-08
The reference study identifies a rapid, non genomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons: reduced PKA activity promotes endocytosis of Kv2.1 channel clusters, which in turn destabilizes surface CaV1.2. Its combination of calcium imaging, channel trafficking assays, reconstituted HEK293 systems, and pharmacological rescue experiments provides a useful framework for studying acute hormone control of neuronal excitability.
-
Isochlorogenic Acid A Hydrogel for Wound Repair
2026-09-07
A 2026 Gels study addressed the formulation limits of Isochlorogenic acid A by co-assembling it with Fe(III) into nanoparticles and embedding them in an amylopectin/carboxymethyl chitosan hydrogel. The resulting dressing combined antibacterial activity, mechanical resilience, self-healing, cell-migration support, and improved wound closure, while also shifting inflammatory and vascularization-associated markers.
-
KG-501: CREB–KIX Inhibitor for Cell Assays
2026-09-05
KG-501 is a small-molecule CREB transcription inhibitor that disrupts CREB–CBP KIX-domain binding. Its reported 6.89 μM CREB-inhibition IC50 supports use as a pathway probe, but evidence does not establish KG-501 as a clinical cancer treatment or as the active antitumor component of Jiedu Xiaozheng Yin.
-
JNJ-10198409: PDGF Receptor Inhibition Workflows
2026-09-05
Build reproducible PDGF-BB signaling assays with JNJ-10198409, an ATP-competitive platelet-derived growth factor receptor inhibitor suited to acute phosphorylation, proliferation, angiogenesis, and stromal remodeling studies. The workflow separates product-supported performance from assay-specific starting conditions, helping researchers troubleshoot selectivity, timing, and endpoint variability.
-
Morning Training Improves Endurance Adaptation in Mice
2026-09-04
Hesketh and colleagues show that endurance training early in the mouse active phase produces a larger improvement in performance than training later in the active phase, despite lower absolute workloads. The study links this timing effect to skeletal-muscle adaptations while finding no difference in endpoint liver or muscle glycogen content, refining how circadian exercise responses should be interpreted.
-
Triacetin: From Metabolic Signal to Translational Tool
2026-09-04
Triacetin, or glyceryl triacetate, is more than a formulation excipient: its conversion to acetate and glycerol creates a mechanistic bridge between substrate metabolism, AMPK signaling, oncology models, and translational assay design.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2
2026-09-03
The reference study identifies marein, a flavonoid glycoside from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular exposure to ABCG2 substrates, including Mitoxantrone, marein restored chemosensitivity in drug-resistant cancer-cell models and provided a mechanistic framework for studying transporter-mediated resistance.
-
Neuromedin S (rat): GPCR Workflow Guide
2026-09-03
Neuromedin S (rat) provides a defined endogenous peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. This guide addresses preparation, assay controls, and QC, but the reagent should not be used to infer potency, therapeutic value, or cross-species performance when directly matched paper evidence is unavailable.